Wednesday, July 8, 2026

pharma · Geographic Atrophy · Geographic Atrophy Secondary to Age-related Macular Degeneration · APLS

Genzyme Europe

News and analysis for Genzyme Europe on NovaPharmaNews — regulatory, clinical, and market coverage.

Gooimeer 10, Naarden, None 1411 DD, NL, WALTHAM, MA HQ
1981 Founded
273 Employees
Public company Type
APLS · NYSE Ticker
Company details
Status
Public
HQ
Gooimeer 10, Naarden, None 1411 DD, NL, WALTHAM, MA
Founded
1981
Employees
273
Programs
20
Drugs
5
Patents
24
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Genzyme Europe — regulatory, clinical, and market coverage.

News and analysis for Genzyme Europe on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Genzyme Europe yet.

Back to company overview →